Skip to Main Content

Author Details

Robert C Onofrio
The Broad Institute of Harvard and MIT
2005
37
34
PMIDPaper TitleJournal TitlePublished Year
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
29360107Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.Sci Data2018
29360107Erratum: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.Sci Data2018
29257133Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.Sci Data2017
28341696A Low-Frequency Inactivating <i>AKT2</i> Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.Diabetes2017
29257133Sequence data and association statistics from 12,940 type 2 diabetes cases and controls.Sci Data2017
28341696A Low-Frequency Inactivating <i>AKT2</i> Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk.Diabetes2017
27398621The genetic architecture of type 2 diabetes.Nature2016
27398621The genetic architecture of type 2 diabetes.Nature2016
25625282Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.PLoS Genet2015
25625282Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.PLoS Genet2015
24677197Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.Hepatology2014
24677197Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.Hepatology2014
23257362Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.J Clin Invest2013
23770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013
24185511Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.Nat Genet2013
23525077Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.Nat Genet2013
23622249Punctuated evolution of prostate cancer genomes.Cell2013
23257362Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.J Clin Invest2013
24185511Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.Nat Genet2013
23622249Punctuated evolution of prostate cancer genomes.Cell2013
23770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013
23525077Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.Nat Genet2013
22610119Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.Nat Genet2012
22544022Absolute quantification of somatic DNA alterations in human cancer.Nat Biotechnol2012
22622578Melanoma genome sequencing reveals frequent PREX2 mutations.Nature2012
22460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012
22722202Sequence analysis of mutations and translocations across breast cancer subtypes.Nature2012
22610119Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.Nat Genet2012
22817889A landscape of driver mutations in melanoma.Cell2012
22722202Sequence analysis of mutations and translocations across breast cancer subtypes.Nature2012
22817889A landscape of driver mutations in melanoma.Cell2012
22460905The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2012
22544022Absolute quantification of somatic DNA alterations in human cancer.Nat Biotechnol2012
22622578Melanoma genome sequencing reveals frequent PREX2 mutations.Nature2012
21430775Initial genome sequencing and analysis of multiple myeloma.Nature2011
22328973Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.Cancer Discov2011
21307934The genomic complexity of primary human prostate cancer.Nature2011
21430775Initial genome sequencing and analysis of multiple myeloma.Nature2011
22001862Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.Cancer Res2011
21798893The mutational landscape of head and neck squamous cell carcinoma.Science2011
21775993Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction.Nat Genet2011
22328973Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.Cancer Discov2011
22001862Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.Cancer Res2011
21775993Comparing strategies to fine-map the association of common SNPs at chromosome 9p21 with type 2 diabetes and myocardial infarction.Nat Genet2011
21798893The mutational landscape of head and neck squamous cell carcinoma.Science2011
21307934The genomic complexity of primary human prostate cancer.Nature2011
20179022Integrative analysis of the melanoma transcriptome.Genome Res2010
21085603Screening for familial APP mutations in sporadic cerebral amyloid angiopathy.PLoS One2010
  • 1 - 50 of 74

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 15
University of California San Diego
Career Start Year 2008
Number of shared co-authors 22
University of Oslo
Career Start Year 2007
Number of shared co-authors 2
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 8
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 17
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2006
Number of shared co-authors 6
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 14
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 20
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 12
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 7
University of Southern California
Career Start Year 2004
Number of shared co-authors 14
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 4
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 12
University of California
Career Start Year 2003
Number of shared co-authors 8
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 17
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 16
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 24
University of Texas M.D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 53
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 13
University of California San Francisco
Career Start Year 2000
Number of shared co-authors 27
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 9
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 52
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 7
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 36
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 14
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 19
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
University of British Columbia
Career Start Year 1995
Number of shared co-authors 83
University of British Columbia
Career Start Year 1993
Number of shared co-authors 103
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 42

Collaborators

Broad Institute of MIT and Harvard
Co-authored papers 26
Broad Institute
Co-authored papers 21
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 20
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 19
Co-authored papers 18
Co-authored papers 17
Co-authored papers 14
The Broad Institute of Harvard and MIT
Co-authored papers 14
Co-authored papers 14
Broad Institute of Harvard and MIT
Co-authored papers 13
Cystic Fibrosis Foundation
Co-authored papers 12
Broad Institute of MIT and Harvard
Co-authored papers 12
Co-authored papers 11
Broad Institute of Harvard and Massachusetts Institute of Technology (MIT)
Co-authored papers 11
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 10
Co-authored papers 10
Massachusetts General Hospital
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Big Data Institute, University of Oxford
Co-authored papers 7
Regeneron Pharmaceuticals Inc.
Co-authored papers 7
The University of Manchester
Co-authored papers 7
The Broad Institute of MIT and Harvard
Co-authored papers 7
Co-authored papers 7
University of Oxford
Co-authored papers 7
University of Michigan ann arbor
Co-authored papers 7
Co-authored papers 7